BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AV-1959R readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AV-1959R\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07827768-678@assetmemo.bio
DTSTAMP:20261121T005733Z
DTSTART;VALUE=DATE:20291015
DTEND;VALUE=DATE:20291016
SUMMARY:AV-1959R: Phase 2 readout est. (NCT07827768)
DESCRIPTION:AV-1959R\, phase 2\, Alzheimer's Disease.\nStudy: AV-1959R Vacc
 ine in Individuals With Preclinical Alzheimer's Disease\nEstimated primary
  completion: 15 October 2029. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/av-1959r#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07827768
URL:https://assetmemo.bio/drug/av-1959r#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
